|
Volumn 347, Issue 7926, 2013, Pages
|
The case for licensing cytosine now for smoking cessation is overwhelming
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTISINE;
NICOTINE PATCH;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
HUMAN;
LETTER;
PRIORITY JOURNAL;
QUALITY ADJUSTED LIFE YEAR;
TOBACCO DEPENDENCE;
ALKALOIDS;
HUMANS;
NICOTINE;
SMOKING CESSATION;
TOBACCO USE CESSATION PRODUCTS;
|
EID: 84885056974
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.f5736 Document Type: Letter |
Times cited : (9)
|
References (3)
|